Skip to main content
. 2020 Sep 29;45(4):293–305. doi: 10.1007/s10484-020-09486-9

Table 2.

Group EEG and self-report data pre and post treatment

Pre-treatment Post-treatment Test statistics
M (SD) M (SD) Wilcoxon p r
Neurofeedback (n = 18)
Somatic self-efficacy 2.93 (0.91) 3.79 (0.81) 6.5  < .001** .58
EEG high beta % 4.68 (2.97) 3.19 (1.32) 130.0 .027* .32
EEG low beta % 7.34 (4.21) 6.27 (2.93) 114.0 .115 .21
EEG SMR % 7.97 (3.86) 8.12 (3.63) 83.0 .466 .02
EEG alpha % 13.80 (6.96) 15.85 (6.96) 53.0 .084 .24
EEG theta % 16.89 (5.00) 17.79 (4.67) 57.0 .115 .21
EEG delta % 49.32 (16.43) 48.80 (11.87) 100.0 .276 .11
Binge eating episodes 4.38 (2.77) 3.27 (3.34) 105.5 .027* .33
Mental imagery (n = 18)
Somatic self-efficacy 2.71 (0.89) 3.41 (1.06) 16.5 .006** .47
EEG high beta % 4.04 (2.57) 3.39 (2.06) 111.0 .142 .19
EEG low beta % 7.01 (2.80) 6.18 (3.11) 119.0 .077 .24
EEG SMR % 8.85 (3.70) 8.44 (4.42) 97.0 .320 .08
EEG alpha % 16.18 (6.61) 18.12 (8.32) 73.0 .305 .09
EEG theta % 18.39 (3.64) 17.62 (3.19) 113.0 .123 .20
EEG delta % 45.53 (10.50) 46.24 (13.28) 87.0 .483 .01
Binge eating episodes 4.50 (3.84) 2.83 (3.49) 120.0 .020* .35

Test statistics: within-groups t-tests; p-values: one-sided, * p < .05; ** p < .01. Conventions for effect size r: r ≥ .10 small effect; r ≥ .30 medium effect; r ≥ .50 large effect. For p-values of group-comparisons used for hypothesis testing (H1, bold print) are corrected for multiple comparisons (Holm); p-values of all other exploratory comparisons are reported without corrections for multiple testing